Campanacci L, Bellini G, Cosenzi A, Franca G, Piemontesi A
Institute of Medical Pathology, University of Trieste, Italy.
Drugs Exp Clin Res. 1989;15(11-12):591-7.
Much clinical evidence supports the use of angiotensin-converting enzyme inhibitors (ACE-I) as the first-step drugs in the treatment of essential hypertension. The acute and chronic effects of ACE-I on renal function are reviewed in this paper. The kidney is an important target organ of essential hypertension and some antihypertensive drugs have been shown to decrease renal haemodynamic parameters. In hypertensives with normal renal function, ACE-I were demonstrated to be safe drugs: after acute and chronic administration of these drugs, the drop in blood pressure was accompanied by unchanged or increased GFR and RPF, with decreased renal vascular resistance. Only in patients with renovascular hypertension, with bilateral stenosis or solitary kidney, was there a deterioration in renal function.
